References
- Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol 2015;172:27–36.
- Kraft J, Freiman A. Management of acne. CMAJ 2011;183:430–435.
- Ramanathan S, Hebert AA. Management of acne vulgaris. J Pediatr Health Care 2011;25:332–337.
- Lee YH, Scharnitz TP, Muscat J, et al. Laboratory monitoring during isotretinoin therapy for acne. A systematic review and meta-analysis. JAMA Dermatol 2016;152:35–44.
- Hansen TJ, Lucking S, Miller JJ, et al. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol 2016;75:323–328.
- Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997;36:416–418.
- Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009;1:162–169.
- Douer D, Ramezani L, Parker J, Levine AM. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells. Leukemia 2000;14:874–881.
- Seçkin HY, Baş Y, Takçı Z, Kalkan G. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris. Cutan Ocul Toxicol 2016;35:89–91.
- Ataseven A, Ugur Bilgin A. Effects of isotretinoin on the platelet counts and the mean platelet volume in patients with acne vulgaris. Sci World J 2014;2014:156464.
- Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016–1022.
- Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother 2003;37:1622–1624.
- Coto-Segura P, Galache C, Santos-Juanes J, et al. Transient thrombocytopenia probably induced by isotretinoin. Actas Dermosifiliogr 2008;99:743–744.
- Aurousseau MH, Levacher S, Bénéton C, et al. Transient dysfibrinogenemia and thrombocytopenia associated with recurrent acute pancreatitis in the course of isotretinoin therapy. Rev Med Interne 1995;16:622–625.
- Johnson TM, Rapini RP. Isotretinoin-induced thrombocytopenia. J Am Acad Dermatol 1987;17:838–839.
- Hesdorffer CS, Weltman MD, Raftopoulos H, et al. Thrombocytopenia caused by isotretinoin. S Afr Med J 1986;70:705–706.
- Schmutz JL, Barbaud A, Trechot P. Thrombocytosis induced by low-dose isotretinoin. Ann Dermatol Venereol 2002;129:355.
- Jansen T, Altmeyer P. Thrombocytosis induced by low-dose isotretinoin. Int J Dermatol 2000;39:956–957.
- Aul C, Runde V, Gattermann N. All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. Blood 1993;82:2967–2974.
- Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clin Lab Med 2015;35:133–163.
- Borghi A, Mantovani L, Minghetti S, et al. Acute acne flare following isotretinoin administration: potential protective role of low starting dose. Dermatology (Basel) 2009;218:178–180.